Retinoblastoma (RB) is a childhood eye cancer. Currently, chemotherapy, local therapy, and enucleation are the main ways in which these tumors are managed. The present work is the first study that uses constraint-based reconstruction and analysis approaches to identify and explain RB-specific survival strategies, which are RB tumor specific. Importantly, our model-specific secretion profile is also found in RB1-depleted human retinal cells in vitro and suggests that novel biomarkers involved in lipid metabolism may be important. Finally, RBspecific synthetic lethals have been predicted as lipid and nucleoside transport proteins that can aid in novel drug target development.
The retina is a metabolically active tissue that preferentially uses carbohydrates (i.e., glucose and mannose) for energy [1] . In addition, extensive lipid metabolism (e.g., fatty acid metabolism) and vitamin metabolism (e.g., vitamin A and pteridine metabolism), along with specialized amino acid metabolism (e.g., glutamate metabolism and urea cycle), make retinal tissue unique from the rest of the central nervous system. Retinoblastoma (RB) is caused by the loss of RB1 (GeneID: 5925, RB1) function [2] . It is a childhood tumor affecting one or both eyes with an incidence of 1 in 15 000 to 20 000 births [3] [4] [5] . Due to late-stage presentation, mortality is higher in Asia and Africa (35-73%) , when compared to United States (5-13%) [5] [6] [7] . Additionally, patients with germ line mutation are prone to secondary cancers compared to the general population [8] . The medical management for RB involves predominantly chemotherapy, that is, systemic chemotherapy with triple chemotherapy drugs like carboplatin, etoposide, and vincristine. Currently, intravitreal chemotherapy with melphalan and intra-arterial chemotherapy with carboplatin are commonly practiced to save the vision of these children. If these measures fail, enucleation is done [9, 10] . However, both enucleation and chemotherapy have severe side effects, including intellectual and developmental disabilities [11] [12] [13] . Recently, metabolomics on RB samples identified a number of metabolites (majorly from amino acid and lipid metabolism), concentrations of which significantly differed from healthy tissue [14] . This highlights the role of retinoblastoma-specific metabotype and its potential for explaining the underlying pathology.
Constraint-based reconstruction and analysis (COBRA) remains the preferred systems biology tool to gain fundamental knowledge on the genomics and biochemistry of the target organism [15] . In line with this, the human metabolic reconstruction, that is, Recon [16] [17] [18] , has been published accounting for metabolic reactions and their associated enzymes/genes operating in any given human cell. Recon serves as a knowledge base for interrogating human metabolism within any given disease context [19, 20] . Consequently, integration of 'omics' data onto the core metabolic model helps a clearer understanding of the molecular events, (i.e., the genomic, transcriptomic, proteomic, or metabolomic factors) that drive the cancer phenotype [21] . Subsequently, algorithms exist (e.g., GIMME, iMAT, MBA, FastCore, etc.) that can integrate the 'omics' data to generate condition-specific models [22] . A number of studies have employed COBRA modeling strategy, in order to explain the cancer-specific phenotype and its underlying metabolic factors [21, [23] [24] [25] .
Synthetic lethality is a novel concept in cancer research, wherein, genes/reaction pairs when targeted together hinder cell viability [26] . This has been widely explored to develop treatment options with respect to cancer-specific drug targets [26] [27] [28] . Additionally, COBRA modeling approaches have enabled in identification of robust cancer-specific synthetic lethal interactions [29, 30] .
To date, no study exists that uses mathematical modeling to analyze the major functions of retina and their derangement in RB, from the biochemical pathways/metabolism standpoint. Here, we present a constraint-based metabolic model of RB, which uses RNAseq data of healthy as well as patient groups as constraints for generating patient-specific models from the human metabolic network, Recon 2 [17] . The generated models were used to identify the precise metabolic differences between healthy versus RB as well as between the cancer types. The RB-specific secretion profiles as predicted by the models were validated using MS/MS. Furthermore, synthetic lethals associated with RB progression were identified and novel drug targets were suggested.
Materials and methods

Obtaining gene expression data
Normal retina (N = 3, aged 5, 12 and 22 years) samples for RNA sequencing were obtained from PU Shah eye bank at Medical Research Foundation, Sankara Nethralaya. The RB tumors (N = 7) were obtained from informed consent from the parents of the diseased children treated at Vision Research Foundation, Sankara Nethralaya and the protocol was approved by the Institutional Ethics Committee of Vision Research Foundation. We stored the tissues at À80°C until further use.
Normal retina samples were collected from the healthy cadaveric eyes, post corneal transplantation supplied by C U Shah Eye Bank, Medical Research Foundation, Sankara Nethralaya. This study was conducted at Vision Research Foundation, Sankara Nethralaya, India, and was approved by the Vision Research Foundation Institutional Ethics Board (Ethical clearance no: 249B-2011-P).
RNA extraction for RNA-seq RNA was extracted from tumors and normal retina using TRIzol reagent (#15596026, Thermo Fisher Scientific, Waltham, MA, USA) according to manufacturer's protocol. The quality and concentration of RNA were determined on 2200 TapeStation using the RNA-specific Tapes and reagents (#5067-5576, 5577, Agilent Technologies, Santa Clara, CA, USA) and Qubit 3.0 Fluorimeter (#Q33216, Thermo Fisher Scientific) with RNA HS Assay (#Q32852, Thermo Fisher Scientific).
RNA library preparation and RNA-seq
After the RNA passed the defined quality control measures, the library was prepared using the TruSeq RNA Library Prep Kit V2 (#RS-122-2001/RS-122-2002, Illumina Inc., San Diego, CA, USA). Using divalent cations under high temperature, the Ribo-depleted RNA was fragmented. Initially, the firststrand cDNA was developed from fragmented RNA by using reverse transcriptase and random primers, followed by second-strand cDNA synthesis using DNA polymerase I and RNase H. A single 'A' base was added, and cDNA was then ligated to the adapters. This product was purified and amplified using PCR to make the final cDNA library. This library was quantified using Qubit DNA Assay and by using DNATapeStation D1000 Screen Tape (#5067-5582,5583, Agilent Technologies) amplified and sequenced on the HiSeq2500 with 100 bp paired-end chemistry. 
Bioinformatics
The raw fastq files generated during sequencing were first subjected to quality check to filter out substandard data. This was followed by adapter trimming, which was done using CUTADAPT v-1.8dev (ftp://ftp.ensembl.org/pub/release 75/gtf/homo_sapiens/Homo_sapiens.GRCh37). The processed data had no contamination from non-polyA tailed RNAs, mitochondrial genome sequences, ribosomal RNAs, transfer RNAs, adapter sequences due to the usage of BOW-TIE2 v-2.2.4 [31] . The paired-end reads were aligned to reference human genome, GRCh37/hg19 using HISAT v-0.1.7 [32] . The gene expression in normal retina and RB tumors were calculated using FPKM values (Fragments Per Kilobase of transcript per Million mapped reads) using CUFFLINKS v-2.2.1 [33] . Significant differences in the FPKM values for the seven tumors and three retina sample genes were calculated by performing DESeq analysis [34] . DESeq2 was used to get the Differential Gene Expression for RNA-SEQ experiment. This used negative binomial distribution model to calculate the differential expression of the genes and was run on R script. The raw counts represented as a matrix were used as the input for DESeq2. For each sample, the number of sequences, which have been assigned to each gene, was reported. The values in the matrix were un-normalized counts. Deseq2 normalization was based on the retina (N = 3) and retinoblastoma samples (N = 7) as control and 
Building metabolic models
Top-down approach was used to generate the metabolic models from the normal healthy retina and RB patient data. Currently, many variants of the model building algorithms are available, that is, GIMME [35] , iMAT [36] , FastCore [37] , MBA [38] , etc., and herein, we considered iMAT/ Shlomi for model building. Threshold for gene expression, that is, > 1.5 is usually considered [39, 40] . A user-defined threshold of 2 was chosen, such that genes that have an expression value ≥ 2 were considered to be associated with a primary reaction set. The primary reaction set represents reactions with high confidence level to be present in the cell type. We then compared the performance level of the first three algorithms for model building. For sample 1, 3382 reactions formed the primary reaction set, and GIMME captured 66% (2221/3382 reactions), iMAT captured 73% (2466/3382 reactions), and FastCore captured 6% (209/3382 reactions). Clearly iMAT captured the highest number of primary reactions in the model, as compared to GIMME and FastCore. The major reason for this discrepancy lies in the way the algorithm works for generating a draft model. While GIMME optimizes any given function (e.g., biomass reaction), making minimum addition to accomplish a nonzero flux through the defined objective, FastCore aims for flux consistency. iMAT works best for capturing reactions/ pathways associated with the given data input. This is particularly handy for cases where a single objective is not obeyed/ maintained, for example, mammalian cells. The RNAseq data for the three healthy samples were summed up, and a cumulative expression value was considered to represent a single healthy case. Additionally, if a gene is expressed across all the three healthy samples, it is assumed to be present in the combined model that represents the healthy case. This made the comparison to the cancer cases simpler. A data matrix was constructed, using the above threshold. This matrix had index values as 0, 1, and 2, wherein, 0 signifies expression value not meeting the threshold and 1 agreeing with the threshold. An index of 2 was assigned to those with very high expression (i.e., ≥ 100). This matrix is the first-step input for iMAT algorithm. The gap filling was then done using MILP (mixed integer linear programming) approach, maintaining the defined stoichiometric and thermodynamic constraints [36] . The MBA algorithm [38] also uses MILP to generate context-specific models and relies on multiple tissue-specific molecular data. However, model accuracy levels have been shown to be similar for iMAT and MBA [41] . Additionally, iMAT ensured maximum addition of reactions corresponding to highly expressed genes, which were further expected to carry active metabolic flux. At this stage, the models were termed as draft models that required further curation for its reaction and metabolite contents, in order to abide the sanity checks as well as capture true retina biochemistry (described below).
Model curation using literature data
Once the eight draft models (i.e., one model capturing combined healthy data and seven RB RNAseq data) were generated, sanity checks were performed to test the predictive capacity. These tests include (a) non-zero flux through maintenance and biomass reactions, (b) model curation to resolve network gaps, and (c) checks for mass balance. Healthy retina cells do not replicate [42] ; while the addition of biomass reaction to the combined healthy draft model, the deoxynucleotide-triphosphates were removed, and a biomass maintenance reaction was added. This ensured that the healthy model performs only maintenance functions, rather than cellular duplication. Contrastingly, the draft models for RB were added with the biomass reactions as in Recon 2 [17] .
Model validation
Retina function tests
Extensive manual curation of relevant scientific literature was done to formulate 53 metabolic objectives representing the general and unique biochemical functionalities of the retina. Additionally, two negative controls were set up representing the metabolic function that cannot be accomplished by retina alone (see Doc S1 for details). Flux balance analysis [43] (FBA) was used to optimize one function at a time. FBA assumes a steady state, wherein, the sum of the input flux equals the sum of the output flux. This follows as, dx/dt = 0, that is, the change in concentration of metabolites over time is zero. The mass balance for FBA is given as, SÁv = 0. S is the stoichiometric matrix formed by m 9 n (m are the metabolites occupying the row space, and n are the reactions in the column space of S). v is the flux vector for each reaction in the network, hence, is of size n 9 1. FBA optimizes an objective using linear programming, under the given constraints. Optimizing one function at a time gives a clear understanding of the entire metabolic capacity of the cell. Similar tests have been performed both for global human metabolic network [18] as well as cell-specific network of small intestine [44] .
Secretion profile
Metabolites known to be secreted by healthy and RB were checked in the secretion profiles of the respective models. FastFVA [45] was used to calculate the minimum and maximum flux through the exchange reactions to determine the secretion profile. Flux variability analysis uses FBA to maximize and minimize each network reaction under the set constraints.
All fluxes were computed and given in mmolÁgDWÁ À1 h À1 . All simulations were carried out with MATLAB (Mathworks, Inc., Natick, MA, USA) as programming environment, using TOMLAB (TomOpt Inc., Seattle, WA, USA) as a linear programming solver, and the COBRA toolbox [46] .
LC-MS MS methods
Cells RbÀ/À and Rb +/+ were washed in 150 mM sodium chloride and the liquid removed before the cells were collected in 500 µL of chilled Acetonitrile/methanol/water (40/ 40/20) (Sigma, St. Louis, MO, USA, ACS grade). The cells were then vortexed and placed on dry ice. Each pellet was frozen and thawed three times. These were then spun at 21 000 g for 10 min. The lysate was lyophilized and frozen in liquid nitrogen. Before analysis, the samples were resuspended in 20 lL of HPLC water. The LC-MS/MS analysis was done as described in [47] . Briefly, analysis was performed on a 5500 QTRAP hybrid triple quadrupole mass spectrometer (AB/SCIEX, Framingham, MA, USA) coupled to a Prominence UFLC HPLC system (Shimadzu, Kyoto, Japan). 10 lL pools of metabolites were injected and analyzed using selected reaction monitoring (SRM) for 258 water-soluble metabolites. Ions were made using an ESI voltage of +4900 V in (+) ion mode and À4500 V in (À) ion mode. Data points were collected per detected metabolite using a dwell time of 3 ms per SRM transition and a total cycle time of 1.55 s. Delivery to the mass spectrometer was completed under normal phase chromatography conditions using a 4.6 mm i.d 9 10 cm Amide Xbridge HILIC column (Waters Corp, Milford, MA, USA) at 300 mLÁmin À1 . Gradients were measured starting from 85% buffer B (HPLC grade acetonitrile) to 42% B from 0 to 5 min; 42% B to 0% B from 5 to 16 min; 0% B was held from 16 to 24 min; 0% B to 85% B from 24 to 25 min; 85% B was held for 7 min to re-equilibrate the column. Buffer A was comprised of 20 mM ammonium hydroxide/20 mM ammonium acetate (pH = 9.0) in water : acetonitrile (95 : 5). Peak areas from the total ion current for each metabolite SRM transition were integrated using MULTIQUANT v2.0 software (AB/SCIEX).
Analysis of synthetic lethals
Fast-SL algorithm [48] was used to identify all possible synthetic lethals and reaction pairs in healthy retina and different RB metabolic networks. Additionally, we identified potential compensatory reaction pathways for each of the synthetic lethals (O. Mohite & K. Raman, unpublished results) to understand how metabolic fluxes are rerouted when one reaction of a synthetic lethal pair is deleted.
Results and Discussion
In this study, we developed patient-specific metabolic models of healthy retina and RB using iMAT algorithm [36] . The algorithm integrated the RNAseq data from healthy and retinoblastoma patients onto the metabolic model. Additionally, the generated draft models were further manually curated to improve the model contents and predictions. COBRA modeling analysis methods were employed to identify the fundamental biochemical differences between the healthy versus RB models as well as metabolic hallmarks between different RB models. The model prediction with respect to the RB-specific metabolite secretion was confirmed using MS/MS of human retinal cells depleted of RB1. Finally, synthetic lethals for RB was predicted as potential drug targets (Fig. 1 ).
RNAseq data
The gene expression profiling of healthy and RB cells yielded 57 867 transcripts, which mapped to 23, 453 unique Entrez genes with their corresponding expression values (Table S1A ). The differential gene expression analysis using DESeq algorithm exhibited significant fold changes in 16% genes (P < 0.05) among the unique Entrez genes (Table S1B) . When we considered only the metabolic genes satisfying the thresholds (as mentioned in methods section), for building the metabolic models using FPKM values, 2825 genes formed the latter category, that is, 84%. The most recent human metabolic network, Recon 2 [17] , was used to derive subsequent metabolic models of both normal retina and RB. The mapped metabolic genes present in the RNAseq data (i.e., 1713 genes) represented 99% of the genetic content of Recon 2, making Recon 2 as an ideal choice for subsequent investigation.
Model statistics
The first draft models capturing data from the healthy and the RB datasets were curated for their reaction and metabolite content (Table S2) . Since retina cells growing in vivo do not replicate [42] , a 'biomass maintenance reaction' was added to the healthy model and tested for non-zero flux. Additionally, exchange reactions were added for all the metabolites present in the extracellular space of the draft models. This was not performed by the iMAT algorithm and had to be added manually to enable a functional model. Furthermore, phospholipid metabolism was absent in the draft model, hence, added as per evidence from corresponding literature [49] . This ensured high quality of the reaction content of the final model. Similarly, the draft RB models were added with Recon 2 biomass reaction and checked for a non-zero flux. As stated above, addition of exchange reactions further enabled active biomass in the RB models. Although there was not much improvement in resolving dead-ends in the draft models (Table S2) , the final models definitely scored more for their final reaction content that enabled a functional biomass. The final network components of all the models are given in Table 1 , for details follow Table S3 .
Performance for retina function tests
In order to know the major metabolic differences between a healthy and cancerous retina, 55 retina functions tests were formulated and tested, Table 2 . Of these, 49% (27/55) were found to be affected in RB. Interestingly, 70% (19/27) of affected functions were performed differently across the seven RB models (Fig. 2, Table S4 ).
Significant differences between healthy and cancer models
Overall, six of the RB models performed lowly in accomplishing higher flux through the retina function tests (Fig. 2) . Surprisingly, the third RB model achieved 40% higher flux through synthesis of omega-3 essential fatty acids, that is, docosapentaenoic acid (C22:5) and docosahexaenoic acid (C22:6). Furthermore, flux through biomass reaction resulted in 6% increase in this particular RB model (Fig. 2) . It has been previously established that very long-chain fatty acids play critical roles in cancer, that is, for membrane synthesis, resistance to oxidative stress, survival under energy stress, redox balance, proliferation, and invasion [50] . Furthermore, the proto-oncogene RB1 mutation that causes retinoblastoma tumor has also been shown to be involved in deregulation of lipid metabolism [5] . The developed RB model, thus, captured this cellular reprogramming and found that these tumors preferentially use very long-chain fatty acid synthesis for its survival.
The second reaction of urea cycle, that is, ornithine transcarbamylase (GeneID: 5009, OTC, EC 2.1.3.3), has been shown to absent in normal retina [51] . Interestingly, the first reaction of the urea cycle, that is, mitochondrial carbamoyl phosphate synthetase 1 (GeneID: 1373, CPS1, EC 6.3.4.16) was found to be absent across all the seven RB models, hence, the inactive or null flux (Fig. 2) . However, the cytosolic version of CPS1 reaction was retained in the RB models to synthesize carbamoyl-asparate, via the aspartate carbamoyltransferase (GeneID: 790, CAD, EC 2.1.3.2), which is further utilized to derive orotate and uridinebased nucleotides for cellular duplication or biomass. This behavior was not seen in RB model 1, due to which we see a 47% lower flux through the corresponding biomass reaction (Fig. 2) .
The amino acid arginine is an important biomass precursor. Hence, the RB models conserves it via reducing the flux through the arginase reaction (GeneID: 383, 384, ARG1, ARG2, EC 3.5.3.1), by 99% on an average, Fig. 2 . The arginine is then used to synthesize guanidinoacetate (via glycine amidinotransferase, GeneID: 2628, GATM, EC 2.1.4.1), a precursor for phosphocreatine. Phosphocreatine is then used for ATP or energy synthesis, favoring RB model growth. Consequently, the flux through argininosucinate synthetase (GeneID: 445, ASS1, EC 6.3.4.5) and argininosuccinase (GeneID: 435, ASL, EC 4.3.2.1) also drops to conserve arginine, by 88% on an average, across all the seven cancer models. Accordingly, several reports have been published Fig. 1 . Workflow followed in the present study. The RNA sequence data were used to build patient-specific metabolic models (1A). The model building algorithm, iMAT, was used to integrate the data and derive the metabolic models from the human metabolic network, Recon 2 [17] (1B). The models were further curated for their network components to derive functional models (2). The developed models were then used to explain the RB-specific metabolism (3A). The models secretion profile was validated via MS/MS experiments (3B), and potential drug targets predicted via synthetic lethal study (3C). [49] . Lipids in retina aid in regulating the mobility, orientation, regeneration and stability of rhodopsin (i.e., the visual pigment), and thus, are important for proper functioning of the visual cycle [49] . The list of identified phospholipids in the retina is mentioned in Table S7 CTP:phosphocholine cytidyltransferase (EC 2. 
.1), ADNCYC
The ratio of cyclic GMP to cyclic AMP was almost uniform between the different regions of the retina and it is not uniform in the pigmented epithelium. Retina is a complex tissue with multiple cell type, whereas pigmented epithelium is a tissue with similar cell type. The disparity in metabolite composition between the tissues of the eye in normal state creates curiosity to understand the metabolism that drives these reactions [81] Synthesis of cyclic GMP (EC 4.6.1.2), GUACYC stating that arginosuccinate synthetase and arginosuccinase enzymes found to be differentially expressed and somatically silenced in cancer [52] [53] [54] . Furthermore, arginine deprivation and inhibition of urea cycle and arginine biosynthesis have been suggested as potential cancer treatment strategies [55, 56] . In the current study, the generated RB models selectively use arginine for cellular energy. Thus, metabolic modeling can be successfully used to explain the underlying biochemical mechanisms of cancer cell survival. Cholesterol is an important constituent of retinal lipid, accounting for about 2% of the dry weight of retina [49] . The RB models on an average had 47% lower flux through reactions of cholesterol synthesis pathway (Fig. 2) . Consequently, operating cholesterol synthesis reactions at a lower rate preserved the important intermediate, that is, 'nadph' for utilization by other pathways. This was particularly true for RB model 3, wherein, the model had higher flux through 'nadph' utilizing reactions, including the fatty acid elongation, alpha and omega oxidation, cortisol, testosterone, leukotriene synthesis, and peroxisomal beta oxidation pathways, as compared to the healthy model. In line with this, enzymes of cholesterol metabolism have been suggested as potential targets for different tumors [57, 58] .
Significant differences between the RB models
Although the RB models exhibit different biochemical behaviors for a large number of metabolic pathways (Fig. 2) , we next cover those of greatest significance.
Gamma-aminobutyric acid transaminase
Gamma-aminobutyric acid (GABA) is an important neurotransmitter for retinal neurons [59] and confers neurotrophic effects that aid retinal maturation and development [60] . There exists multiple alternative biosynthetic pathways for GABA, for example, aminobutyraldehyde dehydrogenase (GeneID; 223, ALDH9A, 1 EC 1.2.1.19), GABA transaminase (Gene ID: 18, ABAT, EC 2.6.1.19), or glutamate decarboxylase (Gene ID: 2571, GAD1, EC 4.1.1.15). All the RB models run either all of these or different combination of reactions to generate endogenous GABA. Consequently, the dehydrogenase reaction is absent in RB model 1, which is compensated by running the transaminase and decarboxylase reactions. Similarly, RB model 6 lacks the decarboxylase but utilizes alternative pathways. In contrast, RB models 2, 3, 4, 5, and 7 run all the above reactions. Interestingly, GABA has been shown to be involved in cancer cell metastasis Pteridine pathway byproducts are known to protect the tissues of the eye from lightinduced oxidation, along with giving color to the lens. The localization of the enzymes synthesizing pteridine was identified in retina. Tetrahydropteridine, a product of this pathway, is a cofactor for tyrosine and tryptophan hydroxylase [85] Synthesis of tetrahydrobiopterin (EC 1.6.99.7), DHPR and proliferation [61] , and its high concentration has been found in various retinoblastomas [14] . Additionally, the reversible GABA transaminase is operated for synthesis of glutamate and succinate semialdehyde by RB models 2, 3, 5, and 7. Succinate semialdehyde is further converted to succinate, which is driven toward ATP synthesis, via the TCA cycle. Consequently, elevated glutamate levels have also been reported in retinoblastomas and other cancers [14] .
While the RB model 4 runs GABA transaminase in either direction, the RB model 6 runs it majorly for GABA and alpha-keto-glutarate synthesis, wherein, the latter serves energy purpose of the cell.
Ornithine delta-aminotransferase
Ornithine transaminase (Gene ID: 4942, OAT, EC 2.6.1. 13) is an important enzyme for retinal function. Being at the cross roads of glutamate metabolism, this enzyme is required for synthesis of glutamate from alpha-keto-glutarate, and glutamate 5-semialdehyde from ornithine, via transamination. The glutamate 5-semialdehyde is further utilized for proline synthesis. Deficiency of this enzyme causes gyrate atrophy of the choroid and retina (OMIM: 258870) characterized with ornithine accumulation [62] . Interestingly, the RB models 1, 3, 5, and 6 utilized this reaction for synthesis of alpha-keto glutarate for energy resource. The high flux through ornithine synthesis was then compensated via lowering flux through other ornithine synthesis reaction, that is, arginase (GeneID: 383, 384, ARG1, ARG2, EC 3.5.3.1), Fig. 2 .
Long-chain fatty acid synthesis
Polyunsaturated C22 fatty acids, that is, docosapentaenoic acid (C22:5) and docosahexaenoic acid (C22:6), are important retinal membrane lipids, contributing to about 80% of the total polyunsaturates [49]. Other long-chain fatty acids include the arachidonic acid (C20:4) and adrenic acid (C22:4) that make up the membrane lipid composition. The RB model 1, on an average, had 50% lower flux through synthesis of the above-mentioned fatty acids, as compared to the healthy retina model. The RB model 7, however, on an average, had 27% reduced flux through synthesis of only C22:4 and C22:5 fatty acids. Chain length of very long-chain fatty acids has been reported to be used for differentiating between cancer types [63] . Furthermore, metabolic profiling of retinoblastomas revealed that certain RB groups had increased lipids as compared to other RB groups that exhibited very low lipid concentrations [14] . Consequently, in our profile, RB model 3 had higher flux through very long-fatty acid synthesis (as mentioned above), while RB model 1 and 7 had lower flux.
Biomass
The notable difference in biomass flux was observed for RB models 1 and 3, wherein the former had 47% lower flux and the latter had 6% higher flux, respectively.
For other test functions mentioned in Fig. 2 , 'Neuraminidase' and 'Retinoid isomerase 2' were absent in the concerned cancer models, resulting in null flux through these reactions as compared to the healthy retina model.
Comparison of secretion profile
Metabolic differences between the RB and healthy models were further identified based on their secretion profile. On an average, 74% of exchanges were active across the seven RB models, which were compared to the active exchanges in the healthy model, that is, 80%, Table 3. Follow Table S5 for details.
While 22 metabolites were found to be unique to the RB model, and absent in the healthy model, 208 metabolites were found to be shared between healthy and seven RB models, but with distinct flux value (Fig. 3) . The latter set of metabolites was further explored with respect to their secretion pattern and involvement in core metabolic pathways. A majority of the metabolites were found to have a reduced secretion pattern (Fig. 3) . Furthermore, the lipid and amino acid class of metabolites were the top scorers, where in, the flux values were either reduced or increased through their secretion reactions in RB models, as compared to healthy model (Fig. 3) .
The active secretion profile of healthy and RB models was then evaluated for experimental support. While 20% of healthy secretion metabolites were supported via either experimental validation or literature curation, 22% of RB model metabolites were validated (Table S5 ). This discrepancy was mainly seen as much of the evidence was found for nucleotides (32%) and amino acid (28%) class of metabolites. However, in the current study, majority of the model predictions with respect to secretion profile was for lipid class (i.e., 38%, Fig. 3 ). Furthermore, a recent study done on mouse embryonic fibroblast cells also identified that upon knockdown of RB gene resulted in significant changes of cellular lipid composition [64] . Herein, we would like to emphasize on the need for targeted lipidomics experimentation for identification and validation of RB-specific metabolites that could aid in rapid medical diagnostics.
Synthetic lethals and metabolic rerouting analysis
The different RB models show difference in the number of synthetic lethals between them and also when compared to the "healthy model" (Fig. 4) . RB1 contributed the highest number of single (19%) and double (26%) lethals to the total set. Healthy retina model had the lowest numbers, that is, 6% of single and 5% of double lethals of the total. This signifies the robustness of the healthy retina model as compared to the RB models, making the latter group amenable for predicting potential drug targets for curbing cellular biomass/duplication. In line with this, four single lethals and three double lethals were found to be common across all the eight models (Fig. 4) , which highlight their essentiality for network robustness. However, RB1 (34 reaction pairs), RB3 (19 reaction pairs), RB5 (12 reactions pairs), and RB7 (20 reaction pairs) models contained the maximum number of double lethal interactions and highlight the potential of synthetic lethal predictions for identifying cancer subtypes (Fig. 4) . Details of the synthetic lethal single reactions and double lethals (i.e., pairs) can be found in Table S6 . Next, we analyzed how the single and double lethals vary their lethality condition across the eight models. Of the total 223 reactions, 81 unique reactions were considered for this analysis, Table S6 . Interestingly, 79% of these unique reactions (i.e., 64/ 81 in Table S6 ) were found to be non-essential in healthy model. However, these were single or double lethals in at least one of the RB models. Such reactions with higher lethality specific to only RB cells could be studied further for developing potential anticancer drug targets (Table 4) .
We next focused on the 13 single lethal targets suggested by the models to be lethal only in RB but not in healthy. Interestingly, eight of these (i.e., 62%) were found to be either used as drug targets or as prognostic markers for various cancers (Table 4) . Of the remaining five targets, four of which were transport reactions transporting nucleotides and lipids were found to be novel in the current study and need experimental testing. Nevertheless, the potential of nucleoside transporter inhibitors for the treatment of ovarian cancer is already well established [65] . Therefore, we propose the use of lipid and nucleoside transporter inhibitors for retinoblastoma cases.
In order to classify predicted lethal interactions as double lethals, the basis of their precise reaction paring needs to be completely evaluated. Surprisingly, double lethals (very often) result not only due to knockdown of two reactions but also the entire chain of reactions needs to be shutdown. All possible sets of minimal reactions that are required for the rewiring of fluxes between synthetic lethals reaction pairs were identified (Table S6) . Such rerouting analysis gives us a list of important reactions forming compensatory pathways corresponding to a particular synthetic lethal. Hence, all the compensatory pathways need to be considered during early cancer drug development. Visualization of few of the subnetworks with respect to synthetic in healthy retina model was done using Cytoscape [66] (Fig. 4) .
Conclusions
The present study used a constraint-based metabolic modeling approach for explaining the various biochemical phenomenon adopted by RB models for survival. These include preferential usage of arginine, GABA, glutamate, and ornithine metabolism for deriving cellular energy. Additionally, there is underutilization of cholesterol for preserving redox potential, that is, nadph. Furthermore, it is computationally reconfirmed that synthesis of long-chain/very long-chain fatty 
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